Cape Investment Advisory’s Globus Medical GMED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$17.5K Buy
+222
New +$18.9K ﹤0.01% 725
2025
Q3
Sell
-96
Closed -$5.67K 975
2025
Q2
$5.67K Buy
96
+21
+28% +$1.36K ﹤0.01% 736
2025
Q1
$5.49K Hold
75
﹤0.01% 728
2024
Q4
$6.2K Hold
75
﹤0.01% 688
2024
Q3
$5.37K Buy
+75
New +$5.29K ﹤0.01% 686

Other funds holding GMED

Cape Investment Advisory's GMED Position: Q2 2026 in Review

Cape Investment Advisory opened a new position in Globus Medical (GMED) in Q2 2026: 222 shares worth $17.5K. The stake represents ﹤0.01% of the portfolio and ranks #725 among its holdings. This is a return to the name: Cape Investment Advisory previously reported a position in GMED as recently as Q2 2025.

Cape Investment Advisory first reported a position in GMED in Q3 2024 and has held it in 5 quarters since. 129 funds tracked by Wall St. Rank hold GMED as of Q2 2026.

  • Cape Investment Advisory held 222 shares of Globus Medical worth $17.5K as of Q2 2026.
  • Globus Medical was a new Cape Investment Advisory position in Q2 2026.
  • Globus Medical made up ﹤0.01% of Cape Investment Advisory's portfolio in Q2 2026, its #725 holding.
  • Cape Investment Advisory first reported a position in Globus Medical in Q3 2024 and has held it in 5 quarters since.
  • 129 funds tracked by Wall St. Rank held Globus Medical as of Q2 2026.

Based on Cape Investment Advisory's 13F filing for Q2 2026, filed 23 Jul 2026.